Chemical Modifications in Hyaluronic Acid‐Based Electrospun Scaffolds

Abstract

Hyaluronic acid (HA) is a natural, non‐sulfated glycosaminoglycan (GAG) present in ECM. It is involved in different biological functions with appealing properties in cosmetics and pharmaceutical preparations as well as in tissue engineering. Generally, HA has been electrospun in blends with natural or synthetic polymers to produce fibers having diameters in the order of nano and micro‐scale whose pores can host cells able to regenerate damaged tissues. In the last decade, a rich literature on electrospun HA‐based materials arose. Chemical modifications were generally introduced in HA scaffolds to favour crosslinking or conjugation with bioactive molecules. Considering the high solubility of HA in water, HA‐based electrospun scaffolds are cross‐linked to increase the stability in biological fluids. Crosslinking is necessary also to avoid the release of HA from the hybrid scaffold when implanted in‐vivo. Furthermore, to endow the HA based scaffolds with new chemical or biological properties, conjugation of bioactive molecules to HA was widely reported. Herein, we review the existing research classifying chemical modifications on HA and HA‐based electrospun fibers into three categories: i) in‐situ crosslinking of electrospun HA‐based scaffolds ii) off‐site crosslinking of electrospun HA‐based scaffolds; iii) conjugation of biofunctional molecules to HA with focus on peptides.